Classification
- Anatomical main groupVVarious
- Therapeutic subgroupV08
- Pharmacological subgroupV08A
- Chemical subgroupV08AB
- Chemical substanceV08AB07Ioversol
Where it is registered
Each register and historical list with its number of registrations and a few of them.
Canada
Health Canada · 10 registrations
- Optiray 300 (Ultraject)64 % / W/V · Solution · Liebel-Flarsheim Company LLC
- Optiray 30064 % / W/V · Solution · Liebel-Flarsheim Company LLC
- Optiray 32068 % / W/V · Solution · Liebel-Flarsheim Company LLC
- Optiray 320 (Ultraject)68 % / W/V · Solution · Liebel-Flarsheim Company LLC
Spain
AEMPS · 8 registrations
At a glance
- ATC code
- V08AB07
- ATC group
- Various
- Registers
- 9
- Historical lists
- 2
- Registrations
- 60
- With their own page
- 35
- Companies
- 11
All medicines with Ioversol
Human medicines from every register that match Ioversol by substance or by name, a page at a time, so the count can differ from the registrations above. Strengths and packs are on each medicine’s page.
61 search results
| Medicine | Register | Strength | Form | Status | Holder |
|---|---|---|---|---|---|
| Optiray 300 | United States | 64% | injectable | Marketed | Liebel-Flarsheim |
| Optiray 320 | United States | 68% | injectable | Marketed | Liebel-Flarsheim |
| Optiray 350 | United States | 74% | injectable | Marketed | Liebel-Flarsheim |
| Optiray 160 | United States | 34% | injectable | Not marketed | Liebel-Flarsheim |
| Optiray 240 | United States | 51% | injectable | Not marketed | Liebel-Flarsheim |
| OPTIRAY 300 mg/ml SOLUCION INYECTABLE | Spain | 636 mg | solución inyectable | Marketed | Guerbet |
| OPTIRAY 320 mg/ml SOLUCION INYECTABLE | Spain | 678 mg | solución inyectable | Marketed | Guerbet |
| OPTIRAY 350 mg/ml SOLUCION INYECTABLE | Spain | 741 mg | solución inyectable | Marketed | Guerbet |
| OPTIRAY ULTRAJECT 300 mg/ml SOLUCION INYECTABLE | Spain | 636 mg | solución inyectable | Marketed | Guerbet |
| OPTIRAY ULTRAJECT 320 mg/ml SOLUCION INYECTABLE | Spain | 678 mg | solución inyectable | Marketed | Guerbet |
| OPTIRAY ULTRAJECT 350 mg/ml SOLUCION INYECTABLE | Spain | 741 mg | solución inyectable | Marketed | Guerbet |
| Optiray 300, oplossing voor injectie of infusie, 300 mg I/ml | Netherlands | Oplossing voor injectie of infusie | Authorised | Guerbet | |
| Optiray 320, oplossing voor injectie of infusie, 320 mg I/ml | Netherlands | Oplossing voor injectie of infusie | Authorised | Guerbet | |
| Optiray 350, oplossing voor injectie of infusie, 350 mg I/ml | Netherlands | Oplossing voor injectie of infusie | Authorised | Guerbet | |
| Optiray 300 mg joda/ml otopina za injekciju/infuziju | Croatia | otopina za injekciju/infuziju | Marketed | Pharmacol d.o.o. | |
| Optiray 320 mg joda/ml otopina za injekciju/infuziju | Croatia | Otopina za injekciju / infuziju | Marketed | Pharmacol d.o.o. | |
| Optiray 350 mg joda/ml otopina za injekciju/infuziju | Croatia | otopina za injekciju/infuziju | Marketed | Pharmacol d.o.o. | |
| Optiray 350 Injection 74% | Singapore | 741 mg/ml | injection | Authorised | Transmedic Pte LTD |
| Optiray | Brazil | Authorised | Guerbet Imagem do Brasil Ltda | ||
| Optiray 300 | Serbia | 300mg I/mL | rastvor za injekciju/infuziju | Authorised | Medicom DOO ŠAbac |
| Optiray 300 | Serbia | 300mg I/mL | rastvor za injekciju/infuziju | Authorised | Medicom DOO ŠAbac |
| Optiray 300 (Ultraject) | Canada | 64 % / W/V | Solution | Authorised | Liebel-Flarsheim Company LLC |
| Optiray 350 | Serbia | 350mg I/mL | rastvor za injekciju/infuziju | Authorised | Medicom DOO ŠAbac |
| Optiray 350 | Serbia | 350mg I/mL | rastvor za injekciju/infuziju | Authorised | Medicom DOO ŠAbac |
| Optiray 350 | Serbia | 350mg I/mL | rastvor za injekciju/infuziju | Authorised | Medicom DOO ŠAbac |